Skip to content

Retrospective Analysis of Long-term Speech Performance in Cochlear Implant Recipients Using Electro-acoustic Stimulation

Retrospective Analysis of Long-term Speech Performance in Cochlear Implant Recipients Using Electro-acoustic Stimulation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06301568
Enrollment
55
Registered
2024-03-08
Start date
2024-01-22
Completion date
2024-12-02
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cochlear Hearing Loss

Brief summary

This is a retrospective study designed to collect long-term speech perception results for cochlear implants recipients using electro-acoustic-stimulation as measured in the clinical routine and to confirm the performance of sound processors associated with acoustic earhooks.

Interventions

None listed

Sponsors

Advanced Bionics AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Being implanted with HiRes Ultra or HiRes Ultra 3D SlimJ * Being a user of the "acoustic earhook" system * Having provided informed consent regarding use of his/her data for research.

Exclusion criteria

* no

Design outcomes

Primary

MeasureTime frameDescription
Freiburger Monosyllabic Word Recognition Score in QuietThe Freiburger monosyllabic word test is performed 12 months after device activationPercent correct in the Freiburger Monosyllabic Word test

Secondary

MeasureTime frameDescription
Hochmair-Desoyer Schultz and Moser (HSM) Sentence Score or Oldenburger Sentence Test (OlSa) Recognition Score in QuietThe test (HSM or OlSa) is performed 12 months after device activationPercent correct in either the HSM sentence test or the Oldenburger sentence test (score from 0 to 100%)

Countries

Germany

Contacts

PRINCIPAL_INVESTIGATORAndreas Büchner

Hannover Medical School

Baseline characteristics

Characteristic
Age, Continuous62.3 years
STANDARD_DEVIATION 15.5
duration of CI use3.8 years
STANDARD_DEVIATION 2.1
duration of hearing impairment25.4 years
STANDARD_DEVIATION 17.5
Sex: Female, Male
Female
31 Participants
Sex: Female, Male
Male
24 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 15, 2026